Allergy

The Pharmacy Times® Allergy resource center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.

What can we help you find?
[[thumbnail_alt_text]]
Why is this patient listing ciprofloxacin as an allergy?
[[thumbnail_alt_text]]
Pharmacists have a great opportunity to educate patients about how to stay healthy and counsel those in need of symptom relief about their allergy treatment options.
[[thumbnail_alt_text]]
Pharmacists can provide easily accessible and economically reasonable solutions for patients who suffer from allergies.
 
[[thumbnail_alt_text]]
Dupilumab is now the first biologic therapy approved for the patient population.
[[thumbnail_alt_text]]
Inhaler misuse may result in more asthma attacks.
[[thumbnail_alt_text]]
Future studies will help us determine who will most benefit from egg oral immunotherapy.
[[thumbnail_alt_text]]
The needed-free treatment option, ARS-1, is designed to be easy-to-use, convenient and more reliable than other emergency epinephrine treatments for severe allergic reactions.
[[thumbnail_alt_text]]
Teva’s Epinephrine Injection May Not Undercut Mylan’s on Price, but It Could Help in Addressing Shortages
 
[[thumbnail_alt_text]]
Nasal congestion can negatively affect quality of life by interfering with day-to-day activities and disrupting sleep patterns.
[[thumbnail_alt_text]]
A pair of pivotal Phase 3 placebo-controlled trials that evaluated dupilumab (Dupixent, Sanofi and Regeneron) for adults with inadequately-controlled chronic rhinosinusitis with nasal polyps met all primary and secondary endpoints. 
[[thumbnail_alt_text]]
National Penicillin Allergy Day highlights negative impact of Inaccurate allergy diagnoses. 
[[thumbnail_alt_text]]
One lot of Montelukast Sodium Tablets is being voluntarily recalled by Camber Pharmaceuticals, due to a safety risk for consumers.